1. Sperling LC, Sinclair RD, El Shabrawi-Caelen L. Alopecias. In: Dermatology. 4th ed. Bolognia JL, Schaffer JV, Cerroni L (eds.). Elsevier Limited 2018; 1162-85.
2.
Messenger AG, Sinclair RD, Farrant P, Berker D. Acquired disorders of hair. In: Rook’s Textbook of Dermatology. 7th ed. Griffith C, Barker J, Bleiker T, et al (eds.). John Wiley & Sons, West Sussex 2016; 2262-338.
3.
Rudnicka L, Rusek M, Borkowska B. Introduction. In: Atlas of Trichoscopy. Rudnicka L, Olszewska M, Rakowska A (eds.). Springer, London 2012; 3-8.
4.
High WA, Tomasini CF, Argenziano G, Zalaudek I. Basic principles of dermatology. In: Dermatology. 4th ed. Bolognia JL, Schaffer JV, Cerroni L (eds.). Elsevier Limited 2018; 1-43.
5.
Rudnicka L, Olszewska M, Rakowska A, et al. Trichoscopy: a new method for diagnosing hair loss. J Drugs Dermatol 2008; 7: 651-4.
6.
Inui S, Nakajima T, Itami S. Dry dermoscopy in clinical treatment of alopecia areata. J Dermatol 2007; 34: 635-9.
7.
Rakowska A, Rudnicka L. Normal values in trichoscopy. In: Atlas of Trichoscopy. Rudnicka L, Olszewska M, Rakowska A (eds). Springer, London 2012; 111-7.
8.
Rakowska A. Trichoscopy (hair and scalp videodermoscopy) in the healthy female. Method standardization and norms for measurable parameters. J Dermatol Case Rep 2009; 3: 14-9.
9.
Fabris MR, Melo CP, Melo DF. Folliculitis decalvans: the use of dermatoscopy as an auxiliary tool in clinical diagnosis. An Bras Dermatol 2013; 88: 814-6.
10.
Khunkhet S, Vachiramon V, Suchonwanit P. Trichoscopic clues for diagnosis of alopecia areata and trichotillomania in Asians. Int J Dermatol 2017; 56: 161-5.
11.
Miteva M, Tosti A. Hair and scalp dermatoscopy. J Am Acad Dermatol 2012; 67: 1040-8.
12.
Rudnicka L, Rakowska A, Olszewska M. Trichoscopy. How it may help the clinician. Dermatol Clin 2013; 31: 29-41.
13.
Chiramel MJ, Sharma VK, Khandpur S, Sreenivas V. Relevance of trichoscopy in the differential diagnosis of alopecia: a cross-sectional study from North India. Indian J Dermatol Venereol Leprol 2016; 82: 651-8.
14.
Tiwari D, Goyal M, Alam A, Verma A. An enigma of sudden-onset vitiligo after COVID-19 vaccination: a literature review. Indian Dermatol Online J 2023; 14: 708-10.
15.
Cui X, Zhai Y, Wang S, et al. Effect of the COVID-19 pandemic on serum vitamin D levels in people under age 18 years: a systematic review and meta-analysis. Med Sci Monit 2022; 28: e935823.
16.
Chang R, Yen-Ting Chen T, Wang SI, et al. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. EClinicalMedicine 2023; 56: 101783.
17.
Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristics associated with hospitalization for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 2020; 79: 859-66.
18.
Spihlman AP, Gadi N, Wu SC, Moulton VR. COVID-19 and systemic lupus erythematosus: focus on immune rresponse and therapeutics. Front Immunol 2020; 11: 589474.
19.
Schmidt AF, Rubin A, Milgraum D, Wassef C. Vitiligo following COVID-19: a case report and review of pathophysiology. JAAD Case Rep 2022; 22: 47-9.
20.
Macca L, Peterle L, Ceccarelli M, et al. Vitiligo-like lesions and COVID-19: case report and review of vaccination- and infection-associated vitiligo. Vaccines 2022; 10: 1647.
21.
Chatterjee M, Das A. Management of vitiligo amidst the COVID-19 pandemic: a survey and resulting consensus. Indian J Dermatol 2021; 66: 479-83.
22.
Tsai TF, Ng CY. COVID-19 vaccine-associated vitiligo: a cross-sectional study in a tertiary referral center and systematic review. J Dermatol 2023; 50: 982-9.
23.
Li J, Wen W, Mu Z, et al. Prevalence of cutaneous manifestations in COVID-19: a meta-analysis. J Dermatol 2023; 50: 622-36.
24.
Christensen RE, Jafferany M. Association between alopecia areata and COVID-19: a systematic review. JAAD Int 2022; 7: 57-61.
25.
Takahashi T, Ellingson MK, Wong P, et al. Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes. medRxiv 2020; 2020.10.15.20213544.
26.
Conforti C, Giuffrida R, Dianzani C, et al. COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action. Dermatol Ther 2020; 33: e13298.
27.
Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323: 1574-81.
28.
Hu D, Lou X, Meng N, et al. Influence of age and gender on the epidemic of COVID-19 : evidence from 177 countries and territories-an exploratory, ecological study. Wien Klin Wochenschr 2021; 133: 321-30.
29.
Marzano AV, Cassano N, Genovese G, et al. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol 2020; 183: 431-42.
30.
Pairo-Castineira E, Clohisey S, Klaric L, et al. Genetic mechanisms of critical illness in Covid-19. Nature 2020; 591: 92-8.
31.
Spritz RA. The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med 2010; 2: 78.
